Page 1228 - Adams and Stashak's Lameness in Horses, 7th Edition

1194 Index

magnetic resonance imaging (MRI) (cont’d) rehabilitation/physical therapy, 930–934 prognosis, 592
treatment, 591–592
subchondral bone abnormalities of the joint mobilization, 930–931 bucked shin complex and stress fractures
VetBooks.ir foot, 391, 392, 394, 396, 397–408 therapeutic touch, 925 clinical signs, 564
mobilization with movement techniques/
metacarpal/metatarsal condyles,
of the dorsal third metacarpus,
410–411
exercises, 932–934, 935
suspensory ligament branch injuries, 413
563–567
soft tissue mobilization, 931–932
types, 925–927
collateral ligaments of the DIP joint
etiology, 563–564
lesions, 404–405 massage therapy, 925 diagnosis, 564–565
collateral sesamoidean ligament lesions, matrix metalloprotease (MMP) inhibition, other stress fractures of the third
403, 404 laminitis treatment, 500 metacarpal/metatarsal bone,
digital annular ligament lesions, 408 MCP (metacarpophalangeal) joint, racing 566–567
DIP joint lesions, 405–406 Quarter horses, 975–976 prognosis, 566
distal and middle phalanges lesions, meclofenamic acid (MA) see nonsteroidal treatment, 565–566
406–407 anti‐inflammatory drugs deep digital flexor (DDF) tendinitis,
distal sesamoidean impar ligament medial deviation of the carpus (knock 590–591
lesions, 403 knees, carpus valgus), forelimb clinical signs, 590–591
hoof wall lesions, 407 conformation, 84 etiology, 590
lesions that are poorly detectable with medial deviation of the hock (cow hocks or treatment, 591
MRI, 408 tarsal valgus), hindlimb conformation, enostosis‐like lesions (ELLs), 580
MRI abnormalities in the foot, 398–408 88–89 fractures of the condyles of the third
navicular bone lesions, 401–402 medial–lateral hoof balance, foot metacarpal/metatarsal bones (condylar
navicular bursa lesions, 403 conformation, 89, 90 fractures, longitudinal articular
proximal interphalangeal joint medication effects on bone, 846 fractures), 567–571
lesions, 408 meloxicam see nonsteroidal anti‐ clinical signs, 568
retrospective MRI studies of foot inflammatory drugs diagnosis, 568–569
lameness, 399 meniscal and meniscal ligament injuries etiology, 568, 569
sole puncture wounds, 407–408 stifle region, MRI, 424, 425 prognosis, 571
tendinopathy of the DDFT, 398, 400 meniscal injuries treatment, 569–571
ungular cartilages lesions, 407 stifle: femorotibial joint region, 735–737 fractures of the small metacarpal and
high‐field MRI systems, 387–389 clinical signs, 735 metatarsal (splint) bones, 576–580
how to read an equine MRI study, 397 diagnosis, 735–736 clinical signs, 577
indications, 397 etiology, 735 diagnosis, 577–578
ligaments, 393–395 imaging, 735–736 etiology, 577
low‐field MRI systems, 387–389 prognosis, 737 prognosis, 579–580
metacarpal/metatarsal regions, 416–420 treatment, 736–737 treatment, 578–579
desmopathy of the accessory ligament menisci, ultrasonography, 329–331, 331 fractures of the third metacarpal/metatarsal
of the deep digital flexor tendon mesenchymal stem cell (MSC) therapy, (cannon) bone, 571–572
(DDFT), 420 intralesional therapies, 896–897 clinical signs, 571–572
osseous injury of the third metacarpal/ metacarpal/metatarsal regions diagnosis, 571–572
metatarsal bone, 419–420 magnetic resonance imaging (MRI), etiology, 571
proximal suspensory desmopathy, 416–420 prognosis, 572
416–418, 419 desmopathy of the accessory ligament treatment, 572
musculoskeletal system, interpretation of of the deep digital flexor tendon functional anatomy, 14, 15, 17–19
MR images, 393–396 (DDFT), 420 dorsal aspect, 17
physics, 387 osseous injury of the third metacarpal/ medial and lateral aspects, 17–18
principles, 387 metatarsal bone, 419–420 palmar aspect, 18–19
protocols, 389–390 proximal suspensory desmopathy, metacarpal/metatarsal exostosis (splints),
RF coils, 387 416–418, 419 572–576
sequences, 389–390 metacarpal region, Thoroughbred racehorses, clinical signs, 573–574
signal intensity of different tissues, 390, common conditions, 954–955 diagnosis, 574
391, 393 metacarpophalangeal (MCP) joint, racing etiology, 573
stifle region, 424–425 Quarter horses, 975–976 prognosis, 576
bone contusions, 425 metacarpophalangeal and treatment, 575–576
cartilage lesions, 425 metatarsophalangeal (MCP/MTP) nuclear medicine
cruciate ligament injuries, 424–425 joint injuries, jumping/eventing/ abnormal conditions, 363–364,
meniscal and meniscal ligament injuries, dressage, 996 364, 365
424, 425 metacarpophalangeal joint, radiography, normal bone, 351, 351
tarsal region, 421–424 224–236 radiography, 237–240
fractures, 422–423 metacarpophalangeal/metatarsophalangeal Standardbred racehorses, lameness
intertarsal ligament injury, 423 joint conditions, 968
osseous cyst‐like lesions, 423 osteoarthritis (OA), 550–552 superficial digital flexor (SDF) tendinitis
osseous trauma, 422, 423 clinical signs, 550 (bowed tendon), 585–590
osteoarthritis (OA), 422, 423 diagnosis, 551 clinical signs, 586–587
other soft tissue injuries of the tarsus, etiology, 550 diagnosis, 586–587
423–424 prognosis, 552 etiology, 585–586
tarsus, diagnosis of tarsal lameness, treatment, 552 prevention, 590
661–662 metacarpophalangeal/metatarsophalangeal prognosis, 589
tendons, 393–395 joint (fetlock luxation) rehabilitation, 589–590
ultrasonography, MRI/ultrasound fusion: luxation, 556–558 surgical management, 588–589
navigational ultrasound, 335–336 clinical signs, 556–557 treatment, 587–588
manipulation see palpation and manipulation diagnosis, 557 suspensory ligament desmitis, 580–585
manual therapy, 925–927 etiology, 556 clinical signs, 581–582
clinical applications, 927 prognosis, 558 degenerative suspensory ligament
contraindications, 927 treatment, 557–558 desmitis (DSLD), 584–585
joint mobilization and manipulation, metacarpus/metatarsus, 563–592 diagnostic analgesia, 582–583
926–927 accessory ligament of the deep digital diagnostic imaging, 583
massage therapy, 925 flexor tendon (distal check ligament) etiology, 581
mechanisms of action, 927 (ALDDFT) prognosis, 584
mobilization, 926 clinical signs, 591 treatment, 583–584
passive stretching exercises, 925–926 etiology, 591 ultrasonography, 303–312